IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Concert Pharmaceuticals Inc. opposition analysis
COMPANY ANALYSIS
Latest patents of Concert Pharmaceuticals Inc. opposed by its competitors
Patent:
EP3450434
Grant Date:
Feb 24, 2021
Title:
Deuterated Derivatives Of Ruxolitinib
Oppositions:
1
Latest patents of Concert Pharmaceuticals Inc. opposed by its competitors
Patent Number
Grant Date
Title
Total Oppositions
EP3450434
Feb 24, 2021
Deuterated Derivatives Of Ruxolitinib
1
Competitors of Concert Pharmaceuticals Inc.
INCYTE CORPORATION
Want to track Concert Pharmaceuticals Inc.?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch